Marketplace eNewsletter Bi-Monthly | Having trouble viewing this e-mail? Click here.
Pharmaceutical Technology/BioPharm Marketplace eNewsletter


Pharmaceutical Sciences, Manufacturing & Marketplace Report May 8, 2013


  From Cynthia Challener, PhD, Editor, Pharmaceutical Sciences, Manufacturing & Marketplace Report
Welcome to the Pharmaceutical Sciences, Manufacturing & Marketplace Report, a biweekly newsletter of Pharmaceutical Technology and BioPharm International, and an exclusive feature of the new Pharmaceutical Technology/BioPharm International Marketplace, an online community focused on products and services for drug development and manufacturing. The Pharmaceutical Sciences, Manufacturing & Marketplace Report provides insight in five main communities: solid dosage, semisolid, and specialty dosage forms; parenterals; chemical API manufacturing; biologic API manufacturing; and pharmaceutical analysis.

In this edition, we hear from industry members with varying perspectives on one of the issues highlighted at the recent BIO convention held in Chicago last month—monoclonal antibody separation. Leading ion–exchange media manufacturers also discuss commercial-scale ion-exchange chromatography. In other developments, Catalent reviews technologies for fast orally disintegrating products, Evonik discusses recent advances and potential new uses for biodegradable polymers, and authors from Almac discuss carbon-14 labeling of bioconjugates.
  
 

     
 
Biological API Manufacturing
Image Placeholder
Maciej Frolow/Getty Images
Improving the Economics of Monoclonal Antibody Separation

Advances in monoclonal antibody separation technologies are largely driven by the need to increase efficiencies and reduce cost. Click Here to Read More
Join our Biological API Manufacturing Linked-In Community
 
Pharmaceutical Analysis
Image Placeholder
Adam Gault/Getty Images
Advances in Ion-Exchange Chromatography Leading to Increased Efficiencies and Reduced Costs

New ion-exchange chromatography media are more tolerant of varying conditions, making it possible to eliminate process steps. Click Here to Read More
Join our Pharmaceutical Analysis Linked-In Community
 
Solid, Semisolid, and Specialty Dosage Forms
Image Placeholder
Ion-Bogdan Dumitrescu/Getty Images

Orally Disintegrating Technology Provides Both Formulating Challenges and Opportunities

Drug manufacturers today are increasingly challenged to find new, effective methods for the delivery of active pharmaceutical ingredients, and many are discovering that orally disintegrating technologies can help.Click Here to Read More

Join our Solid, Semisolid, and Specialty Dosage Forms Linked-In Community
 
Parenterals
Image Placeholder
Maria Toutoudaki/Getty Images

Advances in Biodegradable Polymer Technologies Facilitate Sustained Release of Parenteral Drugs

New platform technologies and polymer chemistries may facilitate self-administration, longer-term delivery, and targeted delivery of parenteral drugs. Click Here to Read More

Join our Parenterals Linked-In Community
 
Chemical API Manufacturing
Image Placeholder
Alfred Pasieka/Getty Images

Carbon-14 Bioconjugation: Peptides and Antibody-Drug Conjugates

The authors explain how the synergy between peptide and protein technology and radiolabeling groups can enable the manufacture of carbon-14 labeled peptides and antibody-drug conjugates (ADCs). Click Here to Read More

Join our Chemical API Manufacturing Linked-In Community
 
On-Demand Webcast

USP Outlook: Key Program Activity for 2013

USP standards for the identity, strength, quality, and purity of medicines are an integral part of drug development and manufacturing. Modernization of USP monographs and development and revisions to General Chapters is a top priority for the USP Pharmacopeial Convention in 2013. In this webcast, USP experts provide the status and progress of these efforts: Monograph Modernization progress; New General Chapter content for Excipients, Analysis of Elemental Impurities, and Microbiology; and the latest on the Medicines Compendium.
Register for the on-demand webcast.

 
Roche Engineer wins iPad at INTERPHEX
 
Highlights from Pharmaceutical Technology and BioPharm International
Recent articles from Pharmaceutical Technology and BioPharm International

Solid Dosage, Semisolid, and Specialty Dosage Forms

Process Analytical Technology and Process Control in Solid-Dosage Manufacturing (Pharmaceutical Technology)

Industry is moving toward closed-loop control of continuous processing.
Click Here to Read More

Parenterals

Ensuring Sterility of Parenteral Products (Pharmaceutical Technology)

PharmTech speaks with industry experts to gain insight into best practices for sterility assurance. Click Here to Read More

Pharmaceutical Analysis

Moisture Permeation of Pharmaceutical Packaging (Pharmaceutical Technology)

USP is proposing a new performance testing standard for moisture permeation of pharmaceutical packaging. Click Here to Read More

Chemical API Manufacturing

Advancing Flow Chemistry in API Manufacturing (Pharmaceutical Technology)

Continuous flow chemistry offers potential for greater control, improved safety and environmental profiles, and efficient chemical transformations. Click Here to Read More

Biologic API Manufacturing

Translating Stem Cells From Laboratory to Clinic (BioPharm International)

Ontario-area scientists discuss approaches to development of stem-cell therapies.Click Here to Read More



 
Image Placeholder
Image Placeholder Marketplace Report Blog

Perspectives from Cynthia Challener, PhD, editor of the Pharmaceutical Sciences, Manufacturing & Marketplace Report and industry members

Image Placeholder
| Subscribe | Send Feedback | Advertise With Us | Visit pharmabiomarketplace.com |